| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/13/2004 | US20040091851 HCV peptide compositions |
| 05/13/2004 | US20040091578 Treating a protein containing disulfide bonds withthioredoxin, nicotinamide adenine dinucleotide phosphate- thioredoxin reductase and NADPH or dithiothreitol reacting the protein with physiological disulfide; administering |
| 05/13/2004 | US20040091505 Genes encoding proteins with pesticidal activity |
| 05/13/2004 | US20040091503 Lectin compositions and methods for modulating an immune response to an antigen |
| 05/13/2004 | US20040091502 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 05/13/2004 | US20040091501 Immunosuppresor agent derived from morbillivirus |
| 05/13/2004 | US20040091500 Non-naturally occurring mutants from naturally occurring allergens; overall alpha-carbon backbone tertiary structure of the allergens is preserved; use in vaccines; treating allergies; reduced immunoglobulin E (IgE) binding |
| 05/13/2004 | US20040091499 Modified mite allergen and pharmaceutical uses thereof |
| 05/13/2004 | US20040091498 Defensins: use as antiviral agents |
| 05/13/2004 | US20040091497 Use as a biological target for the treatment and diagnosis of schizophrenia and bipolar disorder for example; drug screening; transgenic non-human animals for use as animal models |
| 05/13/2004 | US20040091496 Vaccine |
| 05/13/2004 | US20040091495 Protein |
| 05/13/2004 | US20040091492 Use in tumor therapy; vaccine adjuvant to enhance cytotoxic T-cell (CTL) response; fusion proteins incorporate onto the surface of Major Histocompatibility Complex I expressing cells to increase CTL response to antigens on the cells |
| 05/13/2004 | US20040091489 Reduction of the nonspecific animal toxicity of immunotoxins by mutating the framework regions of the fv to lower the isoelectric point |
| 05/13/2004 | US20040091488 Antigenic constructs of major histocompatibility complex class I antigens with specific carrier molecules, the preparation and use thereof |
| 05/13/2004 | US20040091487 Inhibition of HIV-1 virion production by a transdominant mutant of integrase interactor 1(INI1)/hSNF5 |
| 05/13/2004 | US20040091483 Inhibitor of SNARE effective in preventing cytokinesis in a population of cells; SNARE membrane fusion machinery, syntaxin 2 and endobrevin/VAMP-8; cells become more susceptible to apoptosis; possible use against tumors |
| 05/13/2004 | US20040091481 Method for modulating the binding activity of a novel icam-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes |
| 05/13/2004 | US20040091479 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy |
| 05/13/2004 | US20040091476 Enhance or suppress T-cell activation and proliferation |
| 05/13/2004 | US20040091474 Degradation and detection of TSE infectivity |
| 05/13/2004 | US20040091468 Novel transcriptional mediators of blood vessel development and endothelial differentiation |
| 05/13/2004 | US20040091466 Regulatory protein for nox enzymes |
| 05/13/2004 | US20040091464 Isolated stromal cells for use in the treatment of diseases of the central nervous system |
| 05/13/2004 | US20040091453 Pancreatic langerhans beta cell proliferation promoter and apoptosis inhibitor, and screening of candidate compounds for the e drugs |
| 05/13/2004 | US20040091452 Calcitonin drug-oligomer conjugates, and uses thereof |
| 05/13/2004 | US20040091426 Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes |
| 05/13/2004 | DE10249594A1 Immunisierung gegen Bestandteile des Humanen Immunschwächevirus (HIV) Immunization against components of the human immunodeficiency virus (HIV) |
| 05/13/2004 | CA2505611A1 Activation of hcv-specific cells |
| 05/13/2004 | CA2504178A1 Methods and kits for diagnosing tumorigenicity |
| 05/13/2004 | CA2503888A1 Chimeric cytoplasmic signalling molecules |
| 05/13/2004 | CA2503886A1 Recombinant protein variants |
| 05/13/2004 | CA2503837A1 Ppr peptide sequences capable of restoring male fertility of plants bearing a male sterility-inducing cytoplasm |
| 05/13/2004 | CA2503763A1 Compositions and methods for modifying toxic effects of proteinaceous compounds |
| 05/13/2004 | CA2503697A1 Trimeric binding proteins for trimeric cytokines |
| 05/13/2004 | CA2503670A1 Crystals of insulin analogues and method for the production thereof |
| 05/13/2004 | CA2503330A1 Compositions and methods for the treatment of immune related diseases |
| 05/13/2004 | CA2501180A1 Actriib fusion polypeptides and uses therefor |
| 05/13/2004 | CA2499502A1 Genes whose expression is increased in response to stimulation by corticotropin-releasing hormone |
| 05/13/2004 | CA2499433A1 Crh responsive genes in cns |
| 05/13/2004 | CA2498642A1 Composition for the treatment of infection by flaviviridae viruses |
| 05/13/2004 | CA2498264A1 G protein coupled receptors and uses thereof |
| 05/13/2004 | CA2411729A1 Knock-in mouse prostate cancer model |
| 05/12/2004 | EP1418236A1 Mammalian chemokines |
| 05/12/2004 | EP1418235A2 Intracellular domain of the her-2/neu protein for prevention or treatment of maligancies |
| 05/12/2004 | EP1418185A1 Use of EDG2 receptor in an animal model of heart failure |
| 05/12/2004 | EP1418184A1 Recombinant fusion protein consisting of the p40 and p35 subunits of IL-12 and a ScFv and use thereof |
| 05/12/2004 | EP1418183A1 Cystic fibrosis gene |
| 05/12/2004 | EP1418182A1 Method of preparing peptide fragment having cell death inhibitory activity |
| 05/12/2004 | EP1418181A1 Improving growth characteristics of filamentous microorganisms |
| 05/12/2004 | EP1418180A2 Chimeric chains that code for proteins that induce effects directed against viruses |
| 05/12/2004 | EP1418179A2 Compositions and methods for detecting and modulating rna activity and gene expression |
| 05/12/2004 | EP1417628A2 Computer-based methods of designing molecules |
| 05/12/2004 | EP1417487A2 Epitope testing using hla |
| 05/12/2004 | EP1417353A1 Methods and compositions relating to hpv-associated pre-cancerous and cancerous growths, including cin |
| 05/12/2004 | EP1417348A2 COMPOSITIONS AND METHODS FOR DETECTING MULTIDRUG RESISTANT STRAINS OF i M. TUBERCULOSIS /i HAVING MUTATIONS IN GENES OF THE i MUTT /i FAMILY |
| 05/12/2004 | EP1417344A1 Zinc finger domain libraries |
| 05/12/2004 | EP1417342A2 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 05/12/2004 | EP1417333A2 Pna probes, probe sets, methods and kits pertaining to the detection of candida |
| 05/12/2004 | EP1417328A2 Invasion complex and methods of targeting |
| 05/12/2004 | EP1417322A2 Plant glycogenin homologs and use thereof in starch modification |
| 05/12/2004 | EP1417320A2 Transgenic plants expressing cobalamin binding proteins |
| 05/12/2004 | EP1417315A2 Plant ion channels and methods |
| 05/12/2004 | EP1417314A2 Novel amylases and uses thereof |
| 05/12/2004 | EP1417312A2 Herbicide tolerant cotton plants and methods for producing and identifying same |
| 05/12/2004 | EP1417311A2 Maize basal layer antimicrobial protein polynucleotides and methods of use |
| 05/12/2004 | EP1417310A2 Nucleic acid and amino acid sequences of a vegf variant |
| 05/12/2004 | EP1417309A2 Dna encoding rat bombesin receptor subtype-3 (brs-3) and uses thereof |
| 05/12/2004 | EP1417308A1 Human protooncogene kg-20 and protein encoded therein |
| 05/12/2004 | EP1417299A1 New biopesticide using gene from erwinia pyrifoliaewt 3, novel pathogen that affects asian pear trees |
| 05/12/2004 | EP1417237A1 Process for preparation of polypeptides of interest from fusion peolypeptides |
| 05/12/2004 | EP1417235A1 Method for immobilization of polypeptides |
| 05/12/2004 | EP1417231A2 Modified human thymic stromal lymphopoietin |
| 05/12/2004 | EP1417230A2 Neuregulin-beta isoforms associated with neuronal processes |
| 05/12/2004 | EP1417229A2 Methods and compounds for the targeting of protein to exosomes |
| 05/12/2004 | EP1417228A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/12/2004 | EP1417227A2 Peptides eefective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/12/2004 | EP1417226A1 Derp1 and proderp1 allergen derivatives |
| 05/12/2004 | EP1417225A2 Crystals and structure of luxs |
| 05/12/2004 | EP1417224A2 Secreted proteins |
| 05/12/2004 | EP1417222A1 Isolated polypeptides based on the neutralizing epitope of the p17 protein of hiv useful as vaccines, and neutralzing annti-p17 antibodies which specifically recognize said neutralizing epitope |
| 05/12/2004 | EP1417221A2 Mimotope of neisseria meningitidis lipooligosaccharide and vaccines containing the same |
| 05/12/2004 | EP1417218A1 Tetrahymena metallothionein gene promoter and its use |
| 05/12/2004 | EP1417217A2 Inhibition of behab cleavage and primary central nervous system (cns) tumors |
| 05/12/2004 | EP1416971A1 Gene transfer imaging and uses thereof |
| 05/12/2004 | EP1416964A2 Treatment and prevention of cancerous and pre-cancerous conditions of the liver, lung and esophagus |
| 05/12/2004 | EP1416957A2 Treatment of immune disorders and b cell disorders |
| 05/12/2004 | EP1416954A1 Use of heparin-binding domain of fibronectin for diagnosis and treatment of cancer |
| 05/12/2004 | EP1416951A1 Melanin-concentrating hormone antagonists |
| 05/12/2004 | EP1416947A1 Fermentation medium and method |
| 05/12/2004 | EP1416791A2 An animal model exhibiting cancer, pulmonary emphysema and cardiomyopathy |
| 05/12/2004 | EP1416789A1 Propagation of human hepatoblastoma cell in non-human animals |
| 05/12/2004 | EP1217891A4 Therapeutic methods and compositions using viruses of the recombinant paramyxoviridae family |
| 05/12/2004 | EP1196030B1 Preserving a hemoglobin blood substitute with a transparent overwrap |
| 05/12/2004 | EP1084409B1 Method and device for electrochemical immunoassay of multiple analytes |
| 05/12/2004 | EP1017269A4 Plant genes for sensitivity to ethylene and pathogens |
| 05/12/2004 | EP1014780A4 Method for altering storage organ composition |
| 05/12/2004 | EP1007556B1 Troponin subunits and fragments useful as angiogenesis inhibitors |
| 05/12/2004 | EP1003372A4 A nod factor binding protein from legume roots |
| 05/12/2004 | EP0983381A4 Prediction of coronary artery disease |